INS and metabolic syndrome: Additional experiments were performed in the hepatoblastoma cell line HepG2 (e.g., Figure 1) by treating these cells with FFAs (1 mM of 2:1 oleate:palmitate long-chain FFAs) as a model for steatosis; insulin (50 nM) to reflect insulin resistance; or FFAs combined with insulin to mimic conditions of the metabolic syndrome.